Pearl Huang, Dunad Therapeutics CEO (Ken Richardson, PR Newswire)
Longtime biotech leader Pearl Huang takes the reins as CEO of Novartis-backed upstart
It has only been a few months since Pearl Huang exited the top seat at Cygnal Therapeutics, but now she’s back at the helm …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
